NCT01852565 Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848). Status COMPLETED Phase PHASE1
NCT01848340 An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01848145 Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT01847443 Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations Status COMPLETED Phase PHASE1
NCT01847430 Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder Status COMPLETED Phase PHASE4
NCT01847417 Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions Status COMPLETED Phase PHASE1
NCT01847404 Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT01843621 A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children Status COMPLETED Phase PHASE1/PHASE2
NCT01842633 Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache Status TERMINATED Phase PHASE3
NCT01842620 OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck. Status COMPLETED Phase PHASE4
NCT01842607 A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects Status COMPLETED Phase PHASE3
NCT01837511 Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients Status COMPLETED Phase N/A
NCT01837316 A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma Status COMPLETED Phase PHASE1
NCT01831817 Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity Status COMPLETED Phase PHASE2
NCT01831804 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863 Status COMPLETED Phase PHASE1
NCT01831791 A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia Status COMPLETED Phase PHASE3
NCT01827839 Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster Status COMPLETED Phase PHASE3
NCT01827670 Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity Status COMPLETED Phase PHASE3
NCT01827657 Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects Status COMPLETED Phase PHASE1
NCT01827644 Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers Status COMPLETED Phase PHASE1